Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cefiderocol: Clinical application and emergence of resistance
Liang Wang, Jie Zhu, Liang Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101034-101034
Closed Access | Times Cited: 10

Showing 10 citing articles:

Antibiotic heteroresistance in Klebsiella pneumoniae: Definition, detection methods, mechanisms, and combination therapy
Jia Yao Lin, Zhi Chen Zhu, Jie Zhu, et al.
Microbiological Research (2024) Vol. 283, pp. 127701-127701
Closed Access | Times Cited: 5
The hidden threat: Klebsiella pneumoniae may develop co-resistance to colistin and cefiderocol under pressure of colistin
Xin Chen, Zhewei Sun, Jianguo Chen, et al.
International Journal of Antimicrobial Agents (2025), pp. 107445-107445
Closed Access
Global molecular epidemiology of the incomplete CirA protein related to cefiderocol resistance in Klebsiella pneumoniae : a genome-based study
Haiyan Long, Yu Feng, Zhiyong Zong
Microbiology Spectrum (2025)
Open Access
Siderophore cephalosporins
Malcolm G. P. Page
EcoSal Plus (2025)
Closed Access
An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/avibactam, And Tobramycin Against Carbapenem-Resistant and -Susceptible Pseudomonas aeruginosa
Emel Mataracı Kara, Bekir Özer, Mesut Yılmaz, et al.
Microbial Pathogenesis (2025), pp. 107560-107560
Closed Access
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Charles‐Hervé Vacheron, Anne Kaas, Jean‐Philippe Rasigade, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Cefiderocol as rescue therapy in a cancer immunosuppressed critically ill child: case description and literature review.
Juan Añón-Hidalgo, María Garrido-Rodríguez, María José González-Abad, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 4, pp. 116539-116539
Closed Access | Times Cited: 1
Quaternized Silk Fibroin Nanocarriers Loaded with Chlorin e6 for Photodynamic Elimination of Drug-Resistant Bacteria and Biofilms
Feiyang Xu, Ting Cui, Jun Wang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 10, pp. 12072-12082
Closed Access
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice
David Mokrani, Charles‐Édouard Luyt
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 554-564
Closed Access
Effects of different carbapenemase and siderophore production on cefiderocol susceptibility in Klebsiella pneumoniae
Chengcheng Yang, LIANG WANG, Jingnan Lv, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
Claudia Alteri, Antonio Teri, Maria Francesca Liporace, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access
Characterization and genomic analysis of Salmonella Abortusequi phage, vB_SalP_LDDK01, and its biocontrol application in donkey meat
Shengliang Cao, Xinyu Kong, Yixuan Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Page 1

Scroll to top